Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis

BackgroundExcess iron has been shown to induce diabetes in animal models. However, the results from human epidemiologic studies linking body iron stores and iron intake to the risk of type 2 diabetes mellitus (T2DM) are conflicting. In this study, we aimed to systematically evaluate the available evidence for associations between iron intake, body iron stores, and the risk of T2DM.MethodsA systematic search of the PubMed/MEDLINE and EMBASE databases to the end of 22 April 2012 was performed, and reference lists of retrieved articles were screened. Two reviewers independently evaluated the eligibility of inclusion and extracted the data. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated using random-effects models.ResultsWe reviewed 449 potentially relevant articles, and 11 prospective studies were included in the analysis. A meta-analysis of five studies gave a pooled RR for T2DM of 1.33 (95% CI 1.19 to 1.48; P<0.001) in individuals with the highest level of heme iron intake, compared with those with the lowest level. The pooled RR for T2DM for a daily increment of 1 mg of heme iron intake was 1.16 (1.09 to 1.23, P<0.001). Body iron stores, as measured by ferritin, soluble transferrin receptor (sTfR) and the sTfR:ferritin ratio, were significantly associated with the risk of T2DM. The pooled RRs for T2DM in individuals with the highest versus the lowest intake of ferritin levels was 1.70 (1.27-2.27, P<0.001) before adjustment for inflammatory markers and 1.63 (1.03-2.56, P = 0.036) after adjustment. We did not find any significant association of dietary intakes of total iron, non-heme, or supplemental iron intake with T2DM risk.ConclusionHigher heme iron intake and increased body iron stores were significantly associated with a greater risk of T2DM. Dietary total iron, non-heme iron, or supplemental iron intakes were not significantly associated with T2DM risk.

[1]  H. Lakka,et al.  Relation between iron stores and non-insulin dependent diabetes in men: case-control study , 1998, BMJ.

[2]  G. Ursin,et al.  Meat consumption and the risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies , 2009, Diabetologia.

[3]  A. Michalsen,et al.  Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial , 2012, BMC Medicine.

[4]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[5]  F. Hu,et al.  The role of iron in type 2 diabetes in humans. , 2009, Biochimica et biophysica acta.

[6]  M. Sandhu,et al.  Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study , 2007, Diabetologia.

[7]  I. Egli,et al.  Iron bioavailability and dietary reference values. , 2010, The American journal of clinical nutrition.

[8]  L. Qi,et al.  Iron intake and body iron stores, anaemia and risk of hyperglycaemia among Chinese adults: the prospective Jiangsu Nutrition Study (JIN) , 2009, Public Health Nutrition.

[9]  Hong-Kyu Kim,et al.  Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. , 2011, Metabolism: clinical and experimental.

[10]  J. Manson,et al.  Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. , 2004, JAMA.

[11]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[12]  R. Poulton,et al.  Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. , 2002, Atherosclerosis.

[13]  W. Bao,et al.  Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes mellitus: a HuGE review and meta-analysis. , 2010, American journal of epidemiology.

[14]  A. Negassa,et al.  Biomarkers of body iron stores and risk of developing type 2 diabetes , 2009, Diabetes, obesity & metabolism.

[15]  M. Okubo,et al.  Recovery of pancreatic beta-cell function in hemochromatosis: combined treatment with recombinant human erythropoietin and phlebotomy. , 1997, The American journal of the medical sciences.

[16]  Zumin Shi,et al.  Association Between Serum Ferritin, Hemoglobin, Iron Intake, and Diabetes in Adults in Jiangsu, China A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[17]  J. Manson,et al.  HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. , 2005, Diabetes.

[18]  P. Wilson,et al.  Dietary determinants of iron stores in a free-living elderly population: The Framingham Heart Study. , 1998, The American journal of clinical nutrition.

[19]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[20]  N. Andrews,et al.  Disorders of iron metabolism. , 1999, The New England journal of medicine.

[21]  W. Willett,et al.  Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. , 2004, The American journal of clinical nutrition.

[22]  Y. Naito,et al.  Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. , 2010, American journal of physiology. Endocrinology and metabolism.

[23]  D A Pyke,et al.  Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis. , 1972, The American journal of medicine.

[24]  E. Rimm,et al.  Dietary iron intake and risk of coronary disease among men. , 1994, Circulation.

[25]  M Awai,et al.  Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. , 1979, The American journal of pathology.

[26]  W. Willett,et al.  Body iron stores and their determinants in healthy postmenopausal US women. , 2003, The American journal of clinical nutrition.

[27]  R. Cooksey,et al.  Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. , 2004, Endocrinology.

[28]  Karan P. Singh,et al.  Effects of Cardiorespiratory Fitness on Serum Ferritin Concentration and Incidence of Type 2 Diabetes: Evidence from the Aerobics Center Longitudinal Study (ACLS). , 2008, The review of diabetic studies : RDS.

[29]  J. Cook,et al.  A clinical evaluation of serum ferritin as an index of iron stores. , 1974, The New England journal of medicine.

[30]  J. Manson,et al.  Iron Intake and the Risk of Type 2 Diabetes in Women , 2006, Diabetes Care.

[31]  Zumin Shi,et al.  Body Iron Stores and Dietary Iron Intake in Relation to Diabetes in Adults in North China , 2008, Diabetes Care.

[32]  P. Zimmet,et al.  The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives , 2012, Nature Reviews Endocrinology.

[33]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[34]  M. Stumvoll,et al.  Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. , 2003, Annals of internal medicine.

[35]  T. Lakka,et al.  Body Iron Stores Are Associated With Serum Insulin and Blood Glucose Concentrations: Population study in 1,013 eastern Finnish men , 1997, Diabetes Care.

[36]  F. Facchini.  Effect of Phlebotomy on Plasma Glucose and Insulin Concentrations , 1998, Diabetes Care.

[37]  H. Rienhoff,et al.  Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. , 2010, American journal of physiology. Endocrinology and metabolism.

[38]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. , 2002, Diabetes.

[39]  Sander Greenland,et al.  Generalized Least Squares for Trend Estimation of Summarized Dose–response Data , 2006 .

[40]  F. Hu,et al.  Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population. , 2009, American journal of epidemiology.

[41]  J. Pankow,et al.  A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. , 2007, American journal of epidemiology.

[42]  S. Greenland,et al.  Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. , 1992, American journal of epidemiology.

[43]  S. Lenzen,et al.  Relation Between Antioxidant Enzyme Gene Expression and Antioxidative Defense Status of Insulin-Producing Cells , 1997, Diabetes.

[44]  An Pan,et al.  Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. , 2011, The American journal of clinical nutrition.

[45]  J. Manson,et al.  A prospective study of red meat consumption and type 2 diabetes in middle-aged and elderly women: the women's health study. , 2004, Diabetes care.

[46]  B. Balkau,et al.  Ferritin and Transferrin Are Both Predictive of the Onset of Hyperglycemia in Men and Women Over 3 Years , 2006, Diabetes Care.

[47]  Bai Luo,et al.  Iron Overload and Diabetes Risk: A Shift From Glucose to Fatty Acid Oxidation and Increased Hepatic Glucose Production in a Mouse Model of Hereditary Hemochromatosis , 2010, Diabetes.

[48]  O. Franco,et al.  Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. , 2008, The Journal of clinical endocrinology and metabolism.

[49]  O. Franco,et al.  Excessive body iron stores are not associated with risk of coronary heart disease in women. , 2008, The Journal of nutrition.

[50]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[51]  A. Folsom,et al.  Dietary iron intake and Type 2 diabetes incidence in postmenopausal women: the Iowa Women’s Health Study , 2004, Diabetologia.

[52]  D. Reboussin,et al.  Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. , 2005, Diabetes care.